| Cat. No. |
Product Name |
Information |
| PC-21894 |
IDE397
MAT2A inhibitor
|
IDE397 (GSK4362676, GSK-676, IDE397) is a potent, selective small molecule methionine adenosyltransferase 2a (MAT2A) inhibitor, displays broad anti-tumor activity across a panel of MTAP-deleted patient-derived xenografts. |
| PC-21876 |
MIF agonist MIF20
MIF agonist
|
MIF agonist MIF20 is an allosteric small molecule agonist of macrophage migration inhibitory factor (MIF), binds to MIF and increases its affinity for the cognate MIF receptor CD74, increasing the strength of downstream signal transduction. |
| PC-21825 |
EC5026
sEH inhibitor
|
EC5026 (BPN-19186) is a potent, selective orally active soluble epoxide hydrolase (sEH) inhibitor with IC50 of 0.04 nM, shows potential for the treatment of neuropathic pain. |
| PC-21800 |
LY3509754
IL-17A inhibitor
|
LY3509754 is a potent, selective and oral small molecule inhibitor of IL-17A with high binding potency(KD=2.14 nM), dose-dependently prevents human IL-17A and IL-17AF from binding human IL-17RA. |
| PC-21786 |
UT-59
Scap inhibitor
|
UT-59 is a specific inhibitor of cholesterol-sensing membrane protein Scap, binds to Scap's cholesterol-binding site, blocks SREBP activation and inhibits lipid synthesis. |
| PC-21745 |
G3BP inhibitor b
G3BP inhibitor
|
G3BP inhibitor b (G3Ib) is a specific, peptide mimetic inhibitor of RNA-binding proteins G3BP1/2 with SPR Kd value of 0.15 uM, blocks the association of G3BP with its binding partners and inhibits condensation of G3BP both in vitro and in live cells. |
| PC-21744 |
G3BP inhibitor a
G3BP inhibitor
|
G3BP inhibitor a (G3Ia) is a specific, peptide mimetic inhibitor of RNA-binding proteins G3BP1/2 with SPR Kd value of 0.54 uM, blcoks the association of G3BP with its binding partners and inhibits condensation of G3BP both in vitro and in live cells. |
| PC-21741 |
GPR31 antagonist SAH2
GPR31 inhibitor
|
GPR31 antagonist SAH2 (SLU-0011371) is the first highly potent and selective small molecule GPR31 antagonist, antagonizes 12(S)-HETE-induced β-arrestin recruitment with IC50 of 1.09 uM. |
| PC-21724 |
L6H21
MD-2 inhibitor
|
L6H21 is an orally active, potent and specific myeloid differentiation 2 (MD-2) inhibitor with binding KD value of 33.3 uM, blocks the formation of the LPS-TLR4/MD-2 complex. |
| PC-21705 |
KVS0001
SMG1 inhibitor
|
KVS0001 is a specific and bioavailable small molecule inhibitor of SMG1 kinase, disrupts nonsense mediated decay (NMD). |
| PC-21683 |
AJ2-30
SLC15A4 inhibitor
|
AJ2-30 is a specific small molecule SLC15A4 inhibitor with IFN-α suppression IC50 of 1.8 µM and MDP transport inhibition IC50 of 2.6 µM. |
| PC-21665 |
VY-3-249
ACSS2 inhibitor
|
VY-3-249 is a a potent Acetyl-CoA synthetase 2 (ACSS2) inhibitor with IC50 of 1.2 uM in in vitro biochemical TranScreener assays. |
